Amneal Pharmaceuticals has received FDA approval for erythromycin tablets USP, in 250 mg and 500 mg strengths. The product is a therapeutic equivalent for the reference listed drug (RLD) erythromycin tablets from Arbor Pharmaceuticals and is an immediate release oral tablet. They are packaged in 100-count bottles and are now available to wholesalers, distributors, and direct.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.